Compared to the non-NAFLD group, patients with NAFLD significantly had higher values of BMI (p<0.001), WC (p<0.001), TC (p=0.002), TG (p=0.005), LDL (p=0.005), SGPT (p=0.02), SGOT (p=0.04), HbA1c (p=0.01), and TyG index (p=0.02), as well as HOMA-IR (P<0.001) while QUICKI was significantly lower in NAFLD group (P<0.001). The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.